OR WAIT null SECS
Jill Murphy is Editor of Pharmaceutical Technology.
May 17, 2023
This deal would help the companies merge to work on future projects and conduct research together.
May 16, 2023
The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.
May 15, 2023
Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.
May 12, 2023
This approach is defined as being used to express transcription factor combinations to reprogram human induced pluripotent stem cells (iPSCs).
May 11, 2023
The objective of the partnership is to automate portions of ScaleReady’s CGT manufacturing workflow by using Cellular Origin’s robotic system for sterile liquid transfer.
May 10, 2023
The guidance is to provide information on compliance with applicable regulatory requirements and recommendations.